WILMINGTON—ChristianaCare has become the first health system in Delaware to offer two new FDA-approved, minimally invasive procedures for patients with tricuspid valve disease. These groundbreaking treatments, TriClip and EVOQUE, can repair or replace a failing tricuspid valve without open-heart surgery, giving patients a safer option and faster recovery. New options for tricuspid valve regurgitation The tricuspid valve directs blood flow through …